Cargando…
Exploring the Biomarkers of Sepsis-Associated Encephalopathy (SAE): Metabolomics Evidence from Gas Chromatography-Mass Spectrometry
BACKGROUND: Sepsis-associated encephalopathy (SAE) is a transient and reversible brain dysfunction, that occurs when the source of sepsis is located outside of the central nervous system; SAE affects nearly 30% of septic patients at admission and is a risk factor for mortality. In our study, we soug...
Autores principales: | Zhu, Jing, Zhang, Mu, Han, Tingli, Wu, Hua, Xiao, Zhibo, Lin, Shihui, Wang, Chuanjiang, Xu, Fang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6875220/ https://www.ncbi.nlm.nih.gov/pubmed/31781604 http://dx.doi.org/10.1155/2019/2612849 |
Ejemplares similares
-
Exploring plasma metabolomic changes in sepsis: a clinical matching study based on gas chromatography–mass spectrometry
por: Lin, Shi-Hui, et al.
Publicado: (2020) -
Paediatric sepsis-associated encephalopathy (SAE): a comprehensive review
por: Dumbuya, John Sieh, et al.
Publicado: (2023) -
Vinegar Metabolomics: An Explorative Study of Commercial Balsamic Vinegars Using Gas Chromatography-Mass Spectrometry
por: Pinu, Farhana R., et al.
Publicado: (2016) -
Urinary metabolomics using gas chromatography-mass spectrometry: potential biomarkers for autism spectrum disorder
por: Khan, Zaib Un Nisa, et al.
Publicado: (2022) -
Quantitative metabolomics based on gas chromatography mass spectrometry: status and perspectives
por: Koek, Maud M., et al.
Publicado: (2010)